Clinical Trial

Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a prospective, single-arm, phase II clinical study aimed to evaluate the efficacy and safety of penpulimab combined with chemotherapy in the treatment of locally advanced hypopharyngeal carcinoma.
Trial Details
NCT Number NCT07752394
Lead Sponsor Tang-Du Hospital
Conditions Head & Neck Cancer
Enrollment 15 participants
Start Date 2026-08-23
Primary Completion 2031-08-23 (estimated)
Study Completion 2031-08-23 (estimated)
Updated on ClinicalTrials.gov 2026-08-07